Mediolanum International Funds’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Sell |
19,185
-38,531
| -67% | -$4.83M | 0.03% | 315 |
|
|
2025
Q1 | $6.53M | Buy |
57,716
+1,372
| +2% | +$155K | 0.09% | 218 |
|
|
2024
Q4 | $7.7M | Sell |
56,344
-3,558
| -6% | -$486K | 0.1% | 186 |
|
|
2024
Q3 | $6.88M | Buy |
59,902
+13,809
| +30% | +$1.59M | 0.1% | 208 |
|
|
2024
Q2 | $5.78M | Buy |
46,093
+36,289
| +370% | +$4.55M | 0.09% | 201 |
|
|
2024
Q1 | $1.35M | Buy |
+9,804
| New | +$1.35M | 0.02% | 324 |
|